ADvantage Therapeutics Inc. Company Profile, Contacts & Intelligence

ADvantage Therapeutics Inc. Overview

Headquartered in the Wynwood neighborhood in Miami, ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a central focus on Alzheimer’s disease. The Company’s lead compound AD04™ is an injectable therapy in the process of entering into a confirmatory Phase 2b clinical trials in Europe to evaluate safety and efficacy of the product in early Alzheimer’s Disease. The Company believes that AD04™ may act as an immunomodulator, stimulating and regulating the immune system to reduce AD pathology, rather than limiting therapy to the aggregation of the proteins present once pathology is present. The Company is also exploring additional approaches to mitigating neurodegenerative disease, which it believes will eventually have an overall impact on longevity.

Headquarters

Miami, Florida, United States

Website

www.advantagetherapeutics.com

Industry

Biotechnology

Founded

2021

ADvantage Therapeutics Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

ADvantage Therapeutics Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to ADvantage Therapeutics Inc.

Explore companies in related markets and compare their industry and employee estimates.